Incannex Healthcare Faces Nasdaq Delisting Risk Over Low Share Price

Reuters
Oct 22
<a href="https://laohu8.com/S/IHLXF">Incannex Healthcare</a> Faces Nasdaq Delisting Risk Over Low Share Price

Incannex Healthcare Inc. announced that it has received a notice from the Nasdaq Stock Market stating that the company is not in compliance with the minimum bid price requirement, as its common stock closed below $1.00 per share for 30 consecutive trading days. While this does not immediately affect the company's listing, Incannex has transferred its shares from the Nasdaq Global Market to the Nasdaq Capital Market and has been granted a second 180-day grace period, until April 20, 2026, to regain compliance. The company is actively evaluating options to cure the deficiency, including the possibility of a reverse stock split.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incannex Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-100980), on October 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10